192 related articles for article (PubMed ID: 31632286)
1. QiDiTangShen Granules Activate Renal Nutrient-Sensing Associated Autophagy in db/db Mice.
Wang X; Zhao L; Ajay AK; Jiao B; Zhang X; Wang C; Gao X; Yuan Z; Liu H; Liu WJ
Front Physiol; 2019; 10():1224. PubMed ID: 31632286
[TBL] [Abstract][Full Text] [Related]
2. QiDiTangShen granules modulated the gut microbiome composition and improved bile acid profiles in a mouse model of diabetic nephropathy.
Wei H; Wang L; An Z; Xie H; Liu W; Du Q; Guo Y; Wu X; Li S; Shi Y; Zhang X; Liu H
Biomed Pharmacother; 2021 Jan; 133():111061. PubMed ID: 33378964
[TBL] [Abstract][Full Text] [Related]
3. QiDiTangShen granules alleviates diabetic nephropathy podocyte injury: A network pharmacology study and experimental validation in vivo and vitro.
Gao F; Zhou Y; Yu B; Xie H; Shi Y; Zhang X; Liu H
Heliyon; 2024 Jan; 10(1):e23535. PubMed ID: 38223704
[TBL] [Abstract][Full Text] [Related]
4. QiDiTangShen Granules Reduced Diabetic Kidney Injury by Regulating the Phosphorylation Balance of the Tyrosine and Serine Residues of Insulin Receptor Substrate 1.
Gao X; Liu H; An Z; He Q
Evid Based Complement Alternat Med; 2018; 2018():2503849. PubMed ID: 30050584
[TBL] [Abstract][Full Text] [Related]
5. Interference in the nutrient-sensing and inflammatory signaling pathways by renal autophagy activation in mice with late stage diabetic nephropathy.
Li D; Yuan S; Deng Y
Int Urol Nephrol; 2024 Jan; 56(1):303-311. PubMed ID: 37355515
[TBL] [Abstract][Full Text] [Related]
6. Emodin Ameliorates Renal Damage and Podocyte Injury in a Rat Model of Diabetic Nephropathy via Regulating AMPK/mTOR-Mediated Autophagy Signaling Pathway.
Liu H; Wang Q; Shi G; Yang W; Zhang Y; Chen W; Wan S; Xiong F; Wang Z
Diabetes Metab Syndr Obes; 2021; 14():1253-1266. PubMed ID: 33776462
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
8.
Chen Y; Zheng YF; Lin XH; Zhang JP; Lin F; Shi H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165163
[No Abstract] [Full Text] [Related]
9. Kaempferol attenuated diabetic nephropathy by reducing apoptosis and promoting autophagy through AMPK/mTOR pathways.
Sheng H; Zhang D; Zhang J; Zhang Y; Lu Z; Mao W; Liu X; Zhang L
Front Med (Lausanne); 2022; 9():986825. PubMed ID: 36530875
[TBL] [Abstract][Full Text] [Related]
10. A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation.
Zhang C; Zhu X; Li L; Ma T; Shi M; Yang Y; Fan Q
Diabetes Metab Syndr Obes; 2019; 12():1297-1309. PubMed ID: 31447572
[TBL] [Abstract][Full Text] [Related]
11. Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression.
Zhao H; Li X; Zhao T; Zhang H; Yan M; Dong X; Chen P; Ma L; Li P
PLoS One; 2017; 12(2):e0171475. PubMed ID: 28182710
[TBL] [Abstract][Full Text] [Related]
12. Cyclocarya paliurus triterpenic acids fraction attenuates kidney injury via AMPK-mTOR-regulated autophagy pathway in diabetic rats.
Zhang XX; Jiang CH; Liu Y; Lou DX; Huang YP; Gao M; Zhang J; Yin ZQ; Pan K
Phytomedicine; 2019 Nov; 64():153060. PubMed ID: 31401495
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway.
Kitada M; Kume S; Imaizumi N; Koya D
Diabetes; 2011 Feb; 60(2):634-43. PubMed ID: 21270273
[TBL] [Abstract][Full Text] [Related]
14. Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in db/db mice and high glucose-treated HK-2 cells.
Guo Y; Ran Z; Zhang Y; Song Z; Wang L; Yao L; Zhang M; Xin J; Mao X
Biomed Pharmacother; 2020 Nov; 131():110684. PubMed ID: 33152903
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway.
Li A; Yi B; Han H; Yang S; Hu Z; Zheng L; Wang J; Liao Q; Zhang H
Autophagy; 2022 Apr; 18(4):877-890. PubMed ID: 34432556
[TBL] [Abstract][Full Text] [Related]
16. Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection.
Lee J; Tsogbadrakh B; Yang S; Ryu H; Kang E; Kang M; Kang HG; Ahn C; Oh KH
Biochem Biophys Res Commun; 2021 Jan; 534():1040-1046. PubMed ID: 33121684
[TBL] [Abstract][Full Text] [Related]
17. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
18. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
Zhou G; Cheung AK; Liu X; Huang Y
Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
[TBL] [Abstract][Full Text] [Related]
19. Combination of active components of Xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/Smad pathways in db/db diabetic mice.
Wu JS; Shi R; Lu X; Ma YM; Cheng NN
PLoS One; 2015; 10(3):e0122661. PubMed ID: 25803610
[TBL] [Abstract][Full Text] [Related]
20. Fluorofenidone offers improved renoprotection at early interventions during the course of diabetic nephropathy in db/db mice via multiple pathways.
Xiong X; Mei W; Xie Y; Liu J; Lu M; Peng X; Yang C; Zhang X; Xie M; Luo R; Yuan X; Huang L; Wu L; Qin J; Peng Y; Jia X; Hu G; Tang D; Tao L
PLoS One; 2014; 9(10):e111242. PubMed ID: 25347392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
